Bibliographic Details
| Title: |
Ocular Manifestations of Coronavirus Disease 2019: A Hospital-Based Prospective Study at a Coronavirus Disease Dedicated Tertiary Center |
| Authors: |
Anchal Tripathi, Rajat Chaudhary, Saurabh Kushwaha, Lav Pathak |
| Source: |
Journal of Current Ophthalmology, Vol 36, Iss 2, Pp 176-181 (2024) |
| Publisher Information: |
Wolters Kluwer Medknow Publications, 2024. |
| Publication Year: |
2024 |
| Collection: |
LCC:Ophthalmology |
| Subject Terms: |
coronavirus disease 2019, epidemiology, ophthalmic manifestations, pandemic, public health, severe acute respiratory syndrome coronavirus 2, Ophthalmology, RE1-994 |
| More Details: |
Purpose: To investigate ophthalmic manifestations in coronavirus disease 2019 (COVID-19) patients admitted to a designated COVID-19 center in Northern India during the period from April 13, 2020, to April 13, 2022. This aims to provide a comprehensive understanding of ocular involvement in the context of the pandemic. Methods: This is a hospital-based prospective observational study. All COVID-19-positive (reverse transcriptase polymerase chain reaction positive – via pharyngeal and nasal swabs) patients, who were admitted to our hospital, were included in the study. Upon receiving ophthalmology referrals, patients were seen in the COVID-19 ward, with data collected on demographic distribution, presenting ocular symptoms, and specific ocular findings. Results: Out of 3278 patients admitted to our center, 287 developed ocular symptoms. The study revealed a mean age of 63.8 ± 13.9 years, with males constituting 61.3% of the cases. The mean logMAR best-corrected visual acuity was found to be 0.30 ± 0.60. The mean duration between COVID-19 diagnosis and development of the first ophthalmic symptom was 10.4 ± 9.8 days. The predominant ocular symptoms included redness, discharge, and watering. Anterior segment manifestations were predominant, with conjunctivitis being the most prevalent ocular pathology (74.21%), followed by episcleritis (9.41%) and subconjunctival hemorrhage (7.31%). Conjunctivitis presented bilaterally in 41.5% of these patients, emphasizing its significance in the spectrum of COVID-19 ocular manifestations. Conclusions: This research contributes substantial evidence regarding ophthalmic manifestations in COVID-19 patients. Ophthalmologists should remain vigilant, considering the potential for ocular symptoms to precede respiratory manifestations. The study emphasizes the need for comprehensive patient assessments and preventive measures in ophthalmic practices. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2452-2325 |
| Relation: |
https://journals.lww.com/10.4103/joco.joco_27_24; https://doaj.org/toc/2452-2325 |
| DOI: |
10.4103/joco.joco_27_24 |
| Access URL: |
https://doaj.org/article/bc38ec496b5041db95691a263b81e913 |
| Accession Number: |
edsdoj.bc38ec496b5041db95691a263b81e913 |
| Database: |
Directory of Open Access Journals |
